FDA Patient Engagement Advisory Committee meeting - November 15th

FDA announces Patient Engagement Advisory Committee meeting on utilizing real world data from patient-driven platforms that connect and empower patients. Learn More:

• PEAC meeting details: View the Federal Register Notice
• Learn more about PEAC: Visit the Patient Engagement Advisory Committee webpage
• Interested in becoming a member of PEAC? FDA is recruiting! Contact Letise Williams, Designated Federal Official, at Letise.Williams@fda.hhs.gov or 301-796-8398.
• Social Media: Use #PEAC2018 to stay connected

Call for Student Abstract Proposals

ISPE is now accepting abstracts from students for oral/poster presentations in the area of pharmacoepidemiology and drug safety for our 2019 Mid-Year Meeting in Rome, Italy, held at the Radisson Blu Hotel, from April 6-9, 2019. Current full-time students that are the lead author on the research study are invited to submit abstracts by November 16, 2018, for presentation at this meeting. There will be 12 student oral presentations and 24 student poster presentations.

ICPE 2018/Prague Update

Recordings of the pre-ICPE courses and plenary sessions are available in ISPE Educational Center.

EMA Workshop: Towards improving the availability of medicines in the EU, November 8-9, 2018

The task force set up by European Union (EU) regulators to better address potential problems with medicines’ supply and to avoid shortages recently published its work programme for the coming two years. The task force will organize a multi-stakeholder workshop on November 8-9, 2018 to gather stakeholders’ perspectives on how to address availability issues and to include their input into the deliverables of the task force. It will bring together all stakeholders impacted, including patients, consumers, healthcare professionals, industry, wholesalers/ distributors, parallel distributors, academia and regulators. The meeting will take place at the EMA offices (30 Churchill Place, Canary Wharf, E14 5EU London, United Kingdom). The first day (November 8) will be a technical meeting where industry stakeholders will be invited to join regulators with a view to gathering technical feedback on the work of the Task Force. The second day (November 9) will be a multi-stakeholder meeting where industry stakeholders, healthcare profession- als, patients/consumers and academia/NGOs will be invited to join regulators with a view to gathering multi-stakeholders’ perspectives on the work of the Task Force and discuss how these can contribute to its deliverables. For more information contact MSQDmeeting@ema.europa.eu